Balaji Amines Q2 FY27 Revenue ₹472 Cr, Net Profit ₹67 Cr
Balaji Amines Limited announced its unaudited financial results for the quarter and half year ended September 30th, 2026. Consolidated Q2 FY27 revenue stood at ₹472 crore, a significant increase from ₹348 crore in Q2 FY26. EBITDA was ₹106 crore, and Net Profit was ₹67 crore. The company highlighted the commencement of commercial production at its expanded Acetonitrile (ACN) facility and the successful commissioning of its 100,000 TPA Dimethyl Ether (DME) plant. Further expansion plans include the Unit-I brownfield expansion for EDA derivatives and the Unit-II greenfield project at Chincholi for HCN, NaCN, EDTA, and EDTA-2Na, targeted for commissioning in Q4 FY27. The company is focusing on capacity expansion, import substitution, and value-added specialty chemicals.
Key Highlights
- Consolidated Q2 FY27 revenue increased to ₹472 crore from ₹348 crore in Q2 FY26.
- Net Profit for Q2 FY27 stood at ₹67 crore, up from ₹37 crore in Q2 FY26.
- Expanded Acetonitrile (ACN) facility and 100,000 TPA Dimethyl Ether (DME) plant commissioned.
- Unit-I and Unit-II expansion projects are on track for FY27 commissioning.
- Company focuses on capacity expansion and specialty chemicals for growth.
Price Impact
More from BALAMINES